Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Titel:
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Auteur:
Cohen, Calvin J Andrade-Villanueva, Jaime Clotet, Bonaventura Fourie, Jan Johnson, Margaret A Ruxrungtham, Kiat Wu, Hao Zorrilla, Carmen Crauwels, Herta Rimsky, Laurence T Vanveggel, Simon Boven, Katia